Jun 29, 2025, 13:46
Molecular Upgrade: 2025 Hemophilia Care Hits Next Level
William McKeown recently posted on X:
”Beautiful slide from Maria Elisa Mancuso summarising the molecules which can be used to treat Hemophilia at the European Haemophilia Consortium Leadership Conference.”
Haemophilia management is advancing so rapidly, it’s as if the disease is preparing for early retirement!
The EHC Leadership Conference is in full swing.
From antibodies to gene therapy, Maria Elisa Mancuso took the stage to present an exciting spectrum of treatment strategies set for 2025.
More updates on Hemophilia with Hemostasis Today.
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India